The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Stem Cells Market Research Report 2025

Global Stem Cells Market Research Report 2025

Publishing Date : Mar, 2025

License Type :

Report Code : 1409807

No of Pages : 107

Ask Your Query

Report Description
Table of Content

Synopsis

Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).

The global Stem Cells market was valued at US$ 2753 million in 2023 and is anticipated to reach US$ 5727.2 million by 2030, witnessing a CAGR of 10.9% during the forecast period 2024-2030.

Stem cell industry of the world's major players have Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi - post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen, Takeda (TiGenix), CBR, ViaCord, Esperite, LifeCell, CCBC, VCANBIO, BOYA LIFE, Beike Biotechnology and International Medical, etc, It has a total market share of 45%.

This report aims to provide a comprehensive presentation of the global market for Stem Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cells.

Report Scope

The Stem Cells market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Stem Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Stem Cells companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

Osiris Therapeutics
NuVasive
Chiesi Pharmaceuticals
Medi-post
JCR Pharmaceutical
MolMed
Pharmicell
Anterogen
Takeda (TiGenix)
CBR
ViaCord
Esperite
LifeCell
CCBC
VCANBIO
BOYA LIFE
Beike Biotechnology
International Medical
Global Cord Blood Corporation
Beijing Health-Biotech Group
ABMD

Segment by Type

Stem Cell Storage
Stem Cell Pharmaceutical and Treatment

Segment by Application

Blood Disease
Cancer
Autoimmune Disease
Others

By Region

North America (United States, Canada)
Europe (Germany, France, U.K., Italy, Russia)
Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
Latin America (Mexico, Brazil, Argentina)
Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Stem Cells companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stem Cells Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Stem Cell Storage
1.2.3 Stem Cell Pharmaceutical and Treatment
1.3 Market by Application
1.3.1 Global Stem Cells Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Blood Disease
1.3.3 Cancer
1.3.4 Autoimmune Disease
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Stem Cells Market Perspective (2019-2030)
2.2 Stem Cells Growth Trends by Region
2.2.1 Global Stem Cells Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Stem Cells Historic Market Size by Region (2019-2024)
2.2.3 Stem Cells Forecasted Market Size by Region (2025-2030)
2.3 Stem Cells Market Dynamics
2.3.1 Stem Cells Industry Trends
2.3.2 Stem Cells Market Drivers
2.3.3 Stem Cells Market Challenges
2.3.4 Stem Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stem Cells Players by Revenue
3.1.1 Global Top Stem Cells Players by Revenue (2019-2024)
3.1.2 Global Stem Cells Revenue Market Share by Players (2019-2024)
3.2 Global Stem Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Stem Cells Revenue
3.4 Global Stem Cells Market Concentration Ratio
3.4.1 Global Stem Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stem Cells Revenue in 2023
3.5 Stem Cells Key Players Head office and Area Served
3.6 Key Players Stem Cells Product Solution and Service
3.7 Date of Enter into Stem Cells Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Stem Cells Breakdown Data by Type
4.1 Global Stem Cells Historic Market Size by Type (2019-2024)
4.2 Global Stem Cells Forecasted Market Size by Type (2025-2030)
5 Stem Cells Breakdown Data by Application
5.1 Global Stem Cells Historic Market Size by Application (2019-2024)
5.2 Global Stem Cells Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Stem Cells Market Size (2019-2030)
6.2 North America Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Stem Cells Market Size by Country (2019-2024)
6.4 North America Stem Cells Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Stem Cells Market Size (2019-2030)
7.2 Europe Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Stem Cells Market Size by Country (2019-2024)
7.4 Europe Stem Cells Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Stem Cells Market Size (2019-2030)
8.2 Asia-Pacific Stem Cells Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Stem Cells Market Size by Region (2019-2024)
8.4 Asia-Pacific Stem Cells Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Stem Cells Market Size (2019-2030)
9.2 Latin America Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Stem Cells Market Size by Country (2019-2024)
9.4 Latin America Stem Cells Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stem Cells Market Size (2019-2030)
10.2 Middle East & Africa Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Stem Cells Market Size by Country (2019-2024)
10.4 Middle East & Africa Stem Cells Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Osiris Therapeutics
11.1.1 Osiris Therapeutics Company Detail
11.1.2 Osiris Therapeutics Business Overview
11.1.3 Osiris Therapeutics Stem Cells Introduction
11.1.4 Osiris Therapeutics Revenue in Stem Cells Business (2019-2024)
11.1.5 Osiris Therapeutics Recent Development
11.2 NuVasive
11.2.1 NuVasive Company Detail
11.2.2 NuVasive Business Overview
11.2.3 NuVasive Stem Cells Introduction
11.2.4 NuVasive Revenue in Stem Cells Business (2019-2024)
11.2.5 NuVasive Recent Development
11.3 Chiesi Pharmaceuticals
11.3.1 Chiesi Pharmaceuticals Company Detail
11.3.2 Chiesi Pharmaceuticals Business Overview
11.3.3 Chiesi Pharmaceuticals Stem Cells Introduction
11.3.4 Chiesi Pharmaceuticals Revenue in Stem Cells Business (2019-2024)
11.3.5 Chiesi Pharmaceuticals Recent Development
11.4 Medi-post
11.4.1 Medi-post Company Detail
11.4.2 Medi-post Business Overview
11.4.3 Medi-post Stem Cells Introduction
11.4.4 Medi-post Revenue in Stem Cells Business (2019-2024)
11.4.5 Medi-post Recent Development
11.5 JCR Pharmaceutical
11.5.1 JCR Pharmaceutical Company Detail
11.5.2 JCR Pharmaceutical Business Overview
11.5.3 JCR Pharmaceutical Stem Cells Introduction
11.5.4 JCR Pharmaceutical Revenue in Stem Cells Business (2019-2024)
11.5.5 JCR Pharmaceutical Recent Development
11.6 MolMed
11.6.1 MolMed Company Detail
11.6.2 MolMed Business Overview
11.6.3 MolMed Stem Cells Introduction
11.6.4 MolMed Revenue in Stem Cells Business (2019-2024)
11.6.5 MolMed Recent Development
11.7 Pharmicell
11.7.1 Pharmicell Company Detail
11.7.2 Pharmicell Business Overview
11.7.3 Pharmicell Stem Cells Introduction
11.7.4 Pharmicell Revenue in Stem Cells Business (2019-2024)
11.7.5 Pharmicell Recent Development
11.8 Anterogen
11.8.1 Anterogen Company Detail
11.8.2 Anterogen Business Overview
11.8.3 Anterogen Stem Cells Introduction
11.8.4 Anterogen Revenue in Stem Cells Business (2019-2024)
11.8.5 Anterogen Recent Development
11.9 Takeda (TiGenix)
11.9.1 Takeda (TiGenix) Company Detail
11.9.2 Takeda (TiGenix) Business Overview
11.9.3 Takeda (TiGenix) Stem Cells Introduction
11.9.4 Takeda (TiGenix) Revenue in Stem Cells Business (2019-2024)
11.9.5 Takeda (TiGenix) Recent Development
11.10 CBR
11.10.1 CBR Company Detail
11.10.2 CBR Business Overview
11.10.3 CBR Stem Cells Introduction
11.10.4 CBR Revenue in Stem Cells Business (2019-2024)
11.10.5 CBR Recent Development
11.11 ViaCord
11.11.1 ViaCord Company Detail
11.11.2 ViaCord Business Overview
11.11.3 ViaCord Stem Cells Introduction
11.11.4 ViaCord Revenue in Stem Cells Business (2019-2024)
11.11.5 ViaCord Recent Development
11.12 Esperite
11.12.1 Esperite Company Detail
11.12.2 Esperite Business Overview
11.12.3 Esperite Stem Cells Introduction
11.12.4 Esperite Revenue in Stem Cells Business (2019-2024)
11.12.5 Esperite Recent Development
11.13 LifeCell
11.13.1 LifeCell Company Detail
11.13.2 LifeCell Business Overview
11.13.3 LifeCell Stem Cells Introduction
11.13.4 LifeCell Revenue in Stem Cells Business (2019-2024)
11.13.5 LifeCell Recent Development
11.14 CCBC
11.14.1 CCBC Company Detail
11.14.2 CCBC Business Overview
11.14.3 CCBC Stem Cells Introduction
11.14.4 CCBC Revenue in Stem Cells Business (2019-2024)
11.14.5 CCBC Recent Development
11.15 VCANBIO
11.15.1 VCANBIO Company Detail
11.15.2 VCANBIO Business Overview
11.15.3 VCANBIO Stem Cells Introduction
11.15.4 VCANBIO Revenue in Stem Cells Business (2019-2024)
11.15.5 VCANBIO Recent Development
11.16 BOYA LIFE
11.16.1 BOYA LIFE Company Detail
11.16.2 BOYA LIFE Business Overview
11.16.3 BOYA LIFE Stem Cells Introduction
11.16.4 BOYA LIFE Revenue in Stem Cells Business (2019-2024)
11.16.5 BOYA LIFE Recent Development
11.17 Beike Biotechnology
11.17.1 Beike Biotechnology Company Detail
11.17.2 Beike Biotechnology Business Overview
11.17.3 Beike Biotechnology Stem Cells Introduction
11.17.4 Beike Biotechnology Revenue in Stem Cells Business (2019-2024)
11.17.5 Beike Biotechnology Recent Development
11.18 International Medical
11.18.1 International Medical Company Detail
11.18.2 International Medical Business Overview
11.18.3 International Medical Stem Cells Introduction
11.18.4 International Medical Revenue in Stem Cells Business (2019-2024)
11.18.5 International Medical Recent Development
11.19 Global Cord Blood Corporation
11.19.1 Global Cord Blood Corporation Company Detail
11.19.2 Global Cord Blood Corporation Business Overview
11.19.3 Global Cord Blood Corporation Stem Cells Introduction
11.19.4 Global Cord Blood Corporation Revenue in Stem Cells Business (2019-2024)
11.19.5 Global Cord Blood Corporation Recent Development
11.20 Beijing Health-Biotech Group
11.20.1 Beijing Health-Biotech Group Company Detail
11.20.2 Beijing Health-Biotech Group Business Overview
11.20.3 Beijing Health-Biotech Group Stem Cells Introduction
11.20.4 Beijing Health-Biotech Group Revenue in Stem Cells Business (2019-2024)
11.20.5 Beijing Health-Biotech Group Recent Development
11.21 ABMD
11.21.1 ABMD Company Detail
11.21.2 ABMD Business Overview
11.21.3 ABMD Stem Cells Introduction
11.21.4 ABMD Revenue in Stem Cells Business (2019-2024)
11.21.5 ABMD Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Global Support Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Hospital OT and X-Ray, Cathode Room Doors (Hermetically Sealed Door) Market Research Report 2025

Global Children\'s DHA Market Research Report 2025

Global Marine Derived Drugs Market Research Report 2025

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}